153 related articles for article (PubMed ID: 15736939)
1. The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes.
Trieber CA; Douglas JL; Afara M; Young HS
Biochemistry; 2005 Mar; 44(9):3289-97. PubMed ID: 15736939
[TBL] [Abstract][Full Text] [Related]
2. Defining the molecular components of calcium transport regulation in a reconstituted membrane system.
Reddy LG; Cornea RL; Winters DL; McKenna E; Thomas DD
Biochemistry; 2003 Apr; 42(15):4585-92. PubMed ID: 12693956
[TBL] [Abstract][Full Text] [Related]
3. Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum.
Ferrington DA; Yao Q; Squier TC; Bigelow DJ
Biochemistry; 2002 Nov; 41(44):13289-96. PubMed ID: 12403631
[TBL] [Abstract][Full Text] [Related]
4. Oligomeric interactions between phospholamban molecules regulate Ca-ATPase activity in functionally reconstituted membranes.
Yao Q; Chen LT; Li J; Brungardt K; Squier TC; Bigelow DJ
Biochemistry; 2001 May; 40(21):6406-13. PubMed ID: 11371203
[TBL] [Abstract][Full Text] [Related]
5. Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure.
Reddy LG; Autry JM; Jones LR; Thomas DD
J Biol Chem; 1999 Mar; 274(12):7649-55. PubMed ID: 10075652
[TBL] [Abstract][Full Text] [Related]
6. Superinhibitory phospholamban mutants compete with Ca2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state.
Akin BL; Chen Z; Jones LR
J Biol Chem; 2010 Sep; 285(37):28540-52. PubMed ID: 20622261
[TBL] [Abstract][Full Text] [Related]
7. Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopy.
Young HS; Jones LR; Stokes DL
Biophys J; 2001 Aug; 81(2):884-94. PubMed ID: 11463632
[TBL] [Abstract][Full Text] [Related]
8. Effects of phospholamban transmembrane mutants on the calcium affinity, maximal activity, and cooperativity of the sarcoplasmic reticulum calcium pump.
Trieber CA; Afara M; Young HS
Biochemistry; 2009 Oct; 48(39):9287-96. PubMed ID: 19708671
[TBL] [Abstract][Full Text] [Related]
9. Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer.
Mueller B; Karim CB; Negrashov IV; Kutchai H; Thomas DD
Biochemistry; 2004 Jul; 43(27):8754-65. PubMed ID: 15236584
[TBL] [Abstract][Full Text] [Related]
10. An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban.
Hughes G; Starling AP; Sharma RP; East JM; Lee AG
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):973-9. PubMed ID: 8836146
[TBL] [Abstract][Full Text] [Related]
11. Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca(2+)-ATPase.
Reddy LG; Jones LR; Cala SE; O'Brian JJ; Tatulian SA; Stokes DL
J Biol Chem; 1995 Apr; 270(16):9390-7. PubMed ID: 7721863
[TBL] [Abstract][Full Text] [Related]
12. Phospholamban remains associated with the Ca2+- and Mg2+-dependent ATPase following phosphorylation by cAMP-dependent protein kinase.
Negash S; Yao Q; Sun H; Li J; Bigelow DJ; Squier TC
Biochem J; 2000 Oct; 351(Pt 1):195-205. PubMed ID: 10998362
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12.
Chen Z; Akin BL; Jones LR
J Biol Chem; 2007 Jul; 282(29):20968-76. PubMed ID: 17548345
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the skeletal sarcoplasmic reticulum Ca(2+)-ATPase by phospholamban and negatively charged phospholipids in reconstituted phospholipid vesicles.
Szymańska G; Kim HW; Cuppoletti J; Kranias EG
Mol Cell Biochem; 1992 Sep; 114(1-2):65-71. PubMed ID: 1461259
[TBL] [Abstract][Full Text] [Related]
15. Competitive displacement of wild-type phospholamban from the Ca2+-free cardiac calcium pump by phospholamban mutants with different binding affinities.
Chen Z
J Mol Cell Cardiol; 2014 Nov; 76():130-7. PubMed ID: 25194792
[TBL] [Abstract][Full Text] [Related]
16. Role of leucine 31 of phospholamban in structural and functional interactions with the Ca2+ pump of cardiac sarcoplasmic reticulum.
Chen Z; Stokes DL; Jones LR
J Biol Chem; 2005 Mar; 280(11):10530-9. PubMed ID: 15644311
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
Zhai J; Schmidt AG; Hoit BD; Kimura Y; MacLennan DH; Kranias EG
J Biol Chem; 2000 Apr; 275(14):10538-44. PubMed ID: 10744747
[TBL] [Abstract][Full Text] [Related]
18. Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban.
Thomas DD; Reddy LG; Karim CB; Li M; Cornea R; Autry JM; Jones LR; Stamm J
Ann N Y Acad Sci; 1998 Sep; 853():186-94. PubMed ID: 10603946
[TBL] [Abstract][Full Text] [Related]
19. Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs.
Stroik DR; Ceholski DK; Bidwell PA; Mleczko J; Thanel PF; Kamdar F; Autry JM; Cornea RL; Thomas DD
J Mol Cell Cardiol; 2020 Jan; 138():59-65. PubMed ID: 31751570
[TBL] [Abstract][Full Text] [Related]
20. Phospholamban decreases the energetic efficiency of the sarcoplasmic reticulum Ca pump.
Shannon TR; Chu G; Kranias EG; Bers DM
J Biol Chem; 2001 Mar; 276(10):7195-201. PubMed ID: 11087739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
